Prevalence of Dissociative Disorders in Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

301 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Schizophrenia beginning before 18 years is a clinical entity not well known because of its low incidence and difficulties in the clinical diagnosis.

However, in the investigators clinical practice, due to the specialization of the investigators service, the investigators are led to hospital to receive important feel active of patients meeting the Diagnostic and Statistical Manual of Mental Disorders IV text revision (DSM IV-TR) precose schizophrenia.

The work of us team on the theme of the relationship between Pervasive Developmental Disorders and precose Schizophrenia led us to hypothesize that a number of children in care in the medical and educational institutes, hospitals and day shelters therapeutic part-time symptoms of schizophrenia or a line real early diagnosis of schizophrenia undervalued or not diagnosed.

The main goal is to estimate the prevalence of dissociative disorders in a population of children in care institutions and medical education in child psychiatry in hospitals and others structures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum

NCT01805128

Schizophrenia Autistic Disorder

COMPLETED NA

Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

NCT04370730

Schizophrenia Psychotic Disorders

RECRUITING NA

the Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder.

NCT02565524

Schizophrenia Dissociative Disorders

COMPLETED NA

Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia

NCT04867681

Schizophrenia

ACTIVE_NOT_RECRUITING NA

Influence of Environmental Factors and Schizophrenia

NCT03296384

Patients With Schizophrenia Relatives

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dissociative Disorders Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children with Dissociative Disorders

Children will take first the primary stage. If one child is positive, he will pass the secondary stage.

Group Type EXPERIMENTAL

Primary stage

Intervention Type OTHER

Kiddie-Schedule for Affective Disorders and Schizophrenia

Secondary stage

Intervention Type OTHER

children who are positive to the kiddie-SADS (primary stage), will take the tests: PANSS, Scale for the Assessment of Negative Symptoms (SANS), ADI-R, scale TLC and WISC IV

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Primary stage

Kiddie-Schedule for Affective Disorders and Schizophrenia

Intervention Type OTHER

Secondary stage

children who are positive to the kiddie-SADS (primary stage), will take the tests: PANSS, Scale for the Assessment of Negative Symptoms (SANS), ADI-R, scale TLC and WISC IV

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 7 to 18 years
* Supported in the partner institutions of the study
* IQ\>35 on the certificate of orientation of the Maison Départementale des Personnes Handicapées (MDPH)
* Obtaining the agreement of parents and children